TY  - JOUR
AU  - Williams, Dylan M
AU  - Bandres-Ciga, Sara
AU  - Heilbron, Karl
AU  - Hinds, David
AU  - Noyce, Alastair J
PY  - 2020
DO  - 10.1002/ana.25880
UR  - http://hdl.handle.net/10668/16149
T2  - Annals of neurology
AB  - Long-term exposure to lipid-lowering drugs might affect Parkinson's disease (PD) risk. We conducted Mendelian randomization analyses where genetic variants indexed expected effects of modulating lipid-lowering drug targets on PD. Statin exposure was...
LA  - en
PB  - John Wiley & Sons, Inc.
KW  - Anticholesteremic Agents
KW  - Apolipoprotein A-V
KW  - Apolipoproteins B
KW  - Cholesterol, LDL
KW  - Cholesterol, VLDL
KW  - Humans
KW  - Hypolipidemic Agents
KW  - Mendelian Randomization Analysis
KW  - Parkinson Disease
KW  - Polymorphism, Single Nucleotide
KW  - Treatment Outcome
KW  - Triglycerides
TI  - Evaluating Lipid-Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization.
TY  - research article
VL  - 88
ER  -